A method includes monitoring a sensor signal and classifying a physiological marker of a patient based upon the sensor signal. The method also includes generating a control signal based on the classified physiological marker, the control signal controlling an implantable stimulation device to provide the electrical stimulation at a target site within the patient. The method further includes adapting one or more of a manner in which processor circuitry classifies the physiological markers, generates the control signal, or one or more stimulation parameters of a stimulation program based on the classified physiological markers or patient input so as to automatically adjust one or more of timing or the stimulation parameters of the electrical stimulation.

According to one aspect of the inventive concept there is provided a system for monitoring incontinence comprising: a urine sensitive circuit arranged to present a changed electrical characteristic when exposed to urine; a measurement circuit arranged to perform a measurement on a urine bladder of a wearer to determine at least one parameter which varies with a fill level of the urine bladder; a sensor arranged to determine an orientation and/or a movement of the sensor; and a processing circuit arranged to: determine whether the urine sensitive circuit has been exposed to urine; estimate an amount of urine released on to the urine sensitive circuit; and in response to determining that the urine sensitive circuit has been exposed to urine, record data representing said at least one parameter determined by the measurement circuit, an estimated movement and/or posture of the wearer based on an orientation and/or a movement determined by the sensor, and an estimate of the amount of urine released on to the urine sensitive circuit.

According to one aspect of the inventive concept there is provided a method of monitoring incontinence for a user, comprising: determining, using a urine sensitive circuit provided at an absorbent article and arranged to present a changed electrical characteristic when exposed to urine, whether the user has urinated on the absorbent article, performing, using a measurement circuit, a measurement on the urine bladder to determine a parameter which varies with a fill level of the urine bladder, and in response to determining that the user has urinated on the absorbent article, recording, by a processing circuit, data representing said parameter.

A printed circuit board device includes: a first capacitive sensor configured to measure a first capacitance within a contained volume having known dimensions, wherein the first capacitance changes as a substance is received into the contained volume; a second capacitive sensor having a plurality of trigger points at a plurality of corresponding known heights within the contained volume, the second capacitive sensor configured to detect when the substance received into the contained volume has reached each of the corresponding known heights within the contained volume; and wherein at least one of a level of the substance within the contained volume, a volume of the substance within the contained volume, or a flow rate of the substance into the contained volume is determined based on data from the first capacitive sensor and the second capacitive sensor.

The present application discloses a bladder monitoring system comprising a wearable bladder monitoring device (1) including securing means (27, 29) for securing the device to a subject's (40) body; a phased array (11) of ultrasound transducers (10); and a phased array controller (13) adapted to control the phased array to direct a plurality of ultrasound beams (30, 30, 30) into the subject's body under a range of beam angles, as well as a signal processor (23) adapted to receive data pertaining to echo signals (31, 31, 31) of said ultrasound beams from the phased array. The signal processor is adapted to process said data in order to identify an edge of the subject's pelvic bone (43) proximal to the subject's bladder (41) from data pertaining to at least one of said echo signals; determine an orientation of the wearable bladder monitoring device relative to the pelvic bone based on beam angle information associated with the at least one of said echo signals; and derive bladder information from the data based on the determined orientation. A method of obtaining bladder (volume) information with such a system is also disclosed.

Provided is a biological information estimation device including: a transmission unit 12 and a transmission antenna 13 for emitting radio waves to the heart; a receiving antenna 14 and a receiving unit 15 for receiving either the radio waves which have passed through the heart or the radio waves which have been reflected by the heart; and an estimation unit 11 for estimating the volume of blood contained in the heart and the degree of change in the volume, on the basis of the amplitude or phase of the radio waves received by the receiving unit 15 and the specific absorbed fractions for the heart.

The present relates to a method, system and a device for non-invasive detection of urine flow from the bladder into the kidney(s). The method, system and device rely on measurements made at distinct time points and can be used to detect Vesicoureteral reflux. The method, system and device are designed to detect changes in urine volume in the ureter(s), bladder and/or kidney(s). The method and device measure conductivity changes by bioelectrical impedance or electrical impedance tomography technology.

The various embodiments disclosed here relate to systems, methods, and devices for monitoring bladder health. Certain implementations are directed to patients who require daily catheterization. The various embodiments have at least one tube coupled to a catheter, a pressure sensor, a pump, and a processor. Certain embodiments include a digital device with a software application capable of displaying the monitored readings.

An occupant assist apparatus (12) has: a receiving device (121) for receiving an occupant information relating to an occupant of a vehicle; an estimating device (122) for estimating, on the basis of the occupant information, at least one of a desire of the occupant to urinate and a desire of the occupant to defecate in a future than a timing when the occupant information is received; and an executing device (123) for executing an occupant assist on the basis of a result of an estimation by the estimating device.

Devices, systems, and methods may manage therapy delivery to a patient based on one or more physiological markers. In some examples, a method includes detecting a physiological marker that occurs prior in time to a dysfunctional phase of a physiological cycle, wherein a dysfunctional state of the physiological cycle occurs during the dysfunctional phase without treatment, responsive to detecting the physiological marker, initiating a first phase of the physiological cycle having a duration of time. The method may also include, responsive to the first phase elapsing, controlling a therapy delivery module to deliver neurostimulation therapy during a second phase that begins prior to the dysfunctional phase, wherein the neurostimulation therapy is configured to treat the dysfunctional state.